Kobayashi, Y.; Bustos, M.A.; Shoji, Y.; Jachimowicz, R.D.; Shiloh, Y.; Hoon, D.S.B.
Genomic Amplification of UBQLN4 Is a Prognostic and Treatment Resistance Factor. Cells 2022, 11, 3311.
https://doi.org/10.3390/cells11203311
AMA Style
Kobayashi Y, Bustos MA, Shoji Y, Jachimowicz RD, Shiloh Y, Hoon DSB.
Genomic Amplification of UBQLN4 Is a Prognostic and Treatment Resistance Factor. Cells. 2022; 11(20):3311.
https://doi.org/10.3390/cells11203311
Chicago/Turabian Style
Kobayashi, Yuta, Matias A. Bustos, Yoshiaki Shoji, Ron D. Jachimowicz, Yosef Shiloh, and Dave S. B. Hoon.
2022. "Genomic Amplification of UBQLN4 Is a Prognostic and Treatment Resistance Factor" Cells 11, no. 20: 3311.
https://doi.org/10.3390/cells11203311
APA Style
Kobayashi, Y., Bustos, M. A., Shoji, Y., Jachimowicz, R. D., Shiloh, Y., & Hoon, D. S. B.
(2022). Genomic Amplification of UBQLN4 Is a Prognostic and Treatment Resistance Factor. Cells, 11(20), 3311.
https://doi.org/10.3390/cells11203311